Molecular Subtyping Of Breast Cancer Shows Potential Of Personalized Medicine
A new study at the University of Miami's Sylvester Comprehensive Cancer Center shows the potential of personalized medicine to guide therapy in early-stage, invasive breast cancer. The study in the rapidly advancing field of molecular subtyping was led by Stefan Gluck, M.D., Ph.D., professor of medicine...
More... |
Re: Molecular Subtyping Of Breast Cancer Shows Potential Of Personalized Medicine
Wonderful news. I hope that more information like this becomes available so that women can truly know if they would benefit from chemotherapy.
|
Re: Molecular Subtyping Of Breast Cancer Shows Potential Of Personalized Medicine
Absolutely Wonderful!!! I do believe you said...we will be "dinosaurs.." when all is said and done...
Everyday...new research in the making................................!!!! |
All times are GMT -7. The time now is 09:41 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021